Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

The U.S. government announced quality ratings for 2025 Medicare health and prescription drug plans on Thursday, the first ...

The layoffs are part of CVS’ plans, announced last week, for slashing 2,900 corporate jobs nationwide, as it seeks to cut $2 ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a ...

Profitability pressures are expected to continue, driven by CVS Health's Insurance business. Read more to see why CVS stock ...

CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people ...

CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.

Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.

Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.